details

Peer companies

;

Share Market News

The total revenue surged to Rs. 3.43 millions, up 138.19% for the December 2017 quarter as against Rs. 1.44 millions during the year-ago period.The Net Loss for the quarter ended December 2017 is Rs. -0.08 millions as compared to Net Profit of Rs. 0.96 millions of corresponding quarter ended December 2016Operating profit Margin for the quarter ended December 2017 slipped to -0.08% as compared to 0.96% of corresponding quarter ended December 2016 (Rs. in Million) Quarter ended Year to Date Year ended 201712 201612 % Var 201712 201612 % Var 201703 201603 % Var Sales 3.43 1.44 138.19 12.56 36.21 -65.31 39.60 52.98 -25.25 Other Income 0.01 0.00 0.00 0.35 0.02 1650.00 0.01 0.01 0.00 PBIDT -0.08 0.96 -108.33 -2.09 0.34 -714.71 0.29 -0.07 -514.29 Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PBDT -0.08 0.96 -108.33 -2.09 0.34 -714.71 0.29 -0.07 -514.29 Depreciation 0.00 0.00 0.00 0.00 0.03 0.00 0.01 0.00 0.00 PBT -0.08 0.96 -108.33 -2.09 0.31 -774.19 0.28 -0.07 -500.00 TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT -0.08 0.96 -108.33 -2.09 0.31 -774.19 0.28 -0.07 -500.00 Equity 76.40 76.40 0.00 76.40 76.40 0.00 76.40 76.40 0.00 PBIDTM(%) -2.33 66.67 -103.50 -16.64 0.94 -1872.11 0.73 -0.13 -654.35

Axon Ventures has informed about revised voting result of Postal Ballot.The above information is a part of company’s filings submitted to BSE.

Axon Ventures has submitted a copy of Newspaper Cuttings for postal ballot result.The above information is a part of company’s filings submitted to BSE.

With reference to the Board Meeting held on May 27, 2016, Axon Ventures has now informed that the Board had disapproved the appointment of Shaan Gulecha as additional Director. However it was erroneously informed by the Company in the outcome that Shaan Gulecha was appointed as Director.The above information is a part of company’s filings submitted to BSE.

Axon Ventures has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.The above information is a part of company’s filings submitted to BSE.

Axon Ventures has informed that the Board of Directors of the Company have appointed Girraj Kishor Agrawal, Director of the Company as the Compliance Officer of the Company in place Shruti Shah as she is no longer associated with the Company.The above information is a part of company’s filings submitted to BSE.

Axon Ventures has informed that the Board of Directors of the Company at its meeting held on March 22, 2016, at 12:00 P.M and approved the resignation of Shruti Shah from the post of Company Secretary of the Company.The above information is a part of company’s filings submitted to BSE.

Axon Ventures has informed about standalone Limited Review for the period ended December 31, 2015.The above information is a part of company’s filings submitted to BSE.

Axon Finance has informed that a meeting of the Board of Directors of the Company will be held on November 09, 2015, to consider and approve the Unaudited Financial Results for the quarter ended September 30, 2015. Further, pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and as per the terms of ‘Code of Conduct for Prevention of Insider Trading’ of the Company, the Trading Window shall remain closed from October 24, 2015 to November 11, 2015 for Directors and Designated Employees as defined in the Code.The above information is a part of company’s filings submitted to BSE.

Axon Finance has informed about the details of voting results at the 30th Annual General Meeting (AGM) of the Company held on September 28, 2015, under Clause 35A of Listing Agreement and Scrutinizers Report in this regard.The above information is a part of company’s filings submitted to BSE.

Axon Finance has informed that the 30th Annual General Meeting (AGM) of the Company was held on September 28, 2015.The above information is a part of company’s filings submitted to BSE.

Axon Finance has informed that the Board of Directors of the Company at its meeting held on September 22, 2015, has discussed and approved the appointment of Swati Shinde as an Additional Director of the Company to fill the casual vacancy caused due to death of Jatinkumar Agarrwal.The above information is a part of company’s filings submitted to BSE.